1. Home
  2. THRM vs ADPT Comparison

THRM vs ADPT Comparison

Compare THRM & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRM
  • ADPT
  • Stock Information
  • Founded
  • THRM 1991
  • ADPT 2009
  • Country
  • THRM United States
  • ADPT United States
  • Employees
  • THRM N/A
  • ADPT N/A
  • Industry
  • THRM Auto Parts:O.E.M.
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • THRM Consumer Discretionary
  • ADPT Health Care
  • Exchange
  • THRM Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • THRM 1.2B
  • ADPT 1.2B
  • IPO Year
  • THRM 1993
  • ADPT 2019
  • Fundamental
  • Price
  • THRM $33.08
  • ADPT $8.27
  • Analyst Decision
  • THRM Buy
  • ADPT Buy
  • Analyst Count
  • THRM 3
  • ADPT 5
  • Target Price
  • THRM $51.67
  • ADPT $9.10
  • AVG Volume (30 Days)
  • THRM 262.6K
  • ADPT 1.5M
  • Earning Date
  • THRM 02-19-2025
  • ADPT 02-11-2025
  • Dividend Yield
  • THRM N/A
  • ADPT N/A
  • EPS Growth
  • THRM 68.85
  • ADPT N/A
  • EPS
  • THRM 2.06
  • ADPT N/A
  • Revenue
  • THRM $1,456,124,000.00
  • ADPT $178,957,000.00
  • Revenue This Year
  • THRM $7.75
  • ADPT $20.67
  • Revenue Next Year
  • THRM $6.05
  • ADPT $21.79
  • P/E Ratio
  • THRM $16.06
  • ADPT N/A
  • Revenue Growth
  • THRM N/A
  • ADPT 5.10
  • 52 Week Low
  • THRM $30.25
  • ADPT $2.28
  • 52 Week High
  • THRM $58.17
  • ADPT $8.95
  • Technical
  • Relative Strength Index (RSI)
  • THRM 27.10
  • ADPT 58.94
  • Support Level
  • THRM $30.25
  • ADPT $8.09
  • Resistance Level
  • THRM $36.60
  • ADPT $8.69
  • Average True Range (ATR)
  • THRM 1.46
  • ADPT 0.64
  • MACD
  • THRM -0.34
  • ADPT -0.00
  • Stochastic Oscillator
  • THRM 34.72
  • ADPT 65.66

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: